Related Experiment Video
Updated: Aug 29, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Role of p12(CDK2-AP1) in transforming growth factor-beta1-mediated growth suppression
Miaofen G Hu1, Guo-Fu Hu, Yong Kim
1Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
Abstract:
p12(CDK2-AP1) (p12) is a growth suppressor isolated from normal keratinocytes. Ectopic expression of p12 in squamous carcinoma cells reversed the malignant phenotype of these cells, in part due an ability of p12 to bind to both DNA polymerase alpha/primase and to cyclin-dependent kinase 2 (CDK2), thereby inhibiting their activities. We report in this article that in normal epithelial cells, transforming growth factor beta1 (TGF-beta1) induces p12 expression transcriptionally, which, in turn, mediates the growth inhibitory activity of TGF-beta1. We created inducible p12 antisense HaCaT cell lines [ip12 (-) HaCaT] and showed that selective reduction of cellular p12 resulted in an increase in: (a) CDK2-associated kinase activity; (b) protein retinoblastoma (pRB) phosphorylation; and (c) [(3)H]thymidine incorporation, and partially reversed TGF-beta1-mediated inhibition of CDK2 kinase activity, pRB phosphorylation, and cell proliferation. Furthermore, we generated p12-deficient mouse oral keratinocytes (MOK(p12-/-)) and compared their growth characteristics and response to TGF-beta1 with that of wild-type mouse oral keratinocytes (MOK(WT)). Under normal culture conditions, the number of MOK(p12-/-) in S phase is 2-fold greater than that of MOK(WT). Concomitantly, fewer cells are in G(2) phase in MOK(p12-/-) than that in MOK(WT). Moreover, response to TGF-beta1-mediated growth suppression is compromised in MOK(p12-/-) cells. Mechanistic studies showed that MOK(p12-/-) have increased CDK2 activity and reduced sensitivity to inhibition by TGF-beta1. Collectively our data suggest that p12 plays a role in TGF-beta1-mediated growth suppression by modulating CDK2 activities and pRB phosphorylation.
Insights
p12, a growth suppressor, mediates TGF-beta1
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- p12 (CDK2-AP1) is a known growth suppressor in normal keratinocytes.
- Ectopic p12 expression reverses malignant phenotypes in squamous carcinoma cells by inhibiting DNA polymerase alpha/primase and CDK2.
- Transforming growth factor beta1 (TGF-beta1) is a key regulator of cell growth and differentiation.
Purpose of the Study:
- To investigate the role of p12 in TGF-beta1-mediated growth suppression in normal epithelial cells.
- To elucidate the molecular mechanisms by which p12 mediates TGF-beta1's inhibitory effects.
- To analyze the impact of p12 deficiency on cell cycle regulation and TGF-beta1 response.
Main Methods:
- Creation of inducible p12 antisense HaCaT cell lines (ip12(-) HaCaT).
- Generation of p12-deficient mouse oral keratinocytes (MOK(p12-/-)) and comparison with wild-type (MOK(WT)).
- Assays for CDK2-associated kinase activity, retinoblastoma (pRB) phosphorylation, and DNA synthesis ([(3)H]thymidine incorporation).
Main Results:
- Selective reduction of p12 in ip12(-) HaCaT cells increased CDK2 activity, pRB phosphorylation, and [(3)H]thymidine incorporation.
- p12 deficiency in MOK(p12-/-) cells led to increased S phase, decreased G2 phase, elevated CDK2 activity, and compromised TGF-beta1-mediated growth suppression.
- p12 mediates TGF-beta1's inhibitory effects on CDK2 activity, pRB phosphorylation, and cell proliferation.
Conclusions:
- p12 is a critical mediator of TGF-beta1's growth inhibitory activity in epithelial cells.
- p12 functions by modulating CDK2 activity and pRB phosphorylation.
- p12 plays a significant role in regulating cell proliferation and response to growth factors.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
TGF - β Signaling Pathway
Negative Regulator Molecules
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

